Re: szury w życiu codziennym - Grupy dyskusyjne w eGospodarka.pl

Path: news-archive.icm.edu.pl!news.icm.edu.pl!newsfeed.pionier.net.pl!3.eu.feeder.erj
e.net!feeder.erje.net!weretis.net!feeder8.news.weretis.net!eternal-september.or
g!reader02.eternal-september.org!.POSTED!not-for-mail
From: Jacek Maciejewski <j...@g...pl>
Newsgroups: pl.soc.prawo
Subject: Re: szury w życiu codziennym
Date: Fri, 11 Feb 2022 23:13:48 +0100
Organization: Bambucco.Corp.Ltd
Lines: 27
Message-ID: <94l762l0b0rf$.1us3vt62kwur7.dlg@40tude.net>
References: <1xje66stgv7bq$.brxmx6xmxwc6.dlg@40tude.net>
<su5d8h$1gc4$2@gioia.aioe.org>
<m9ov4pcpmflf$.j7p4z3d63gf7$.dlg@40tude.net>
<su5dt3$1r81$1@gioia.aioe.org>
<1hclqn3vdgfuj$.1t9zo5b1m6yxm.dlg@40tude.net>
<su5g12$sp9$1@gioia.aioe.org> <h...@4...net>
<6206a6fb$0$471$65785112@news.neostrada.pl>
<1o10djw0rsawo$.16zddswnto5r0$.dlg@40tude.net>
<6206b4ac$0$470$65785112@news.neostrada.pl>
<jm107qvapz7a.1fs3q9op5jbzc$.dlg@40tude.net>
<6206d632$0$470$65785112@news.neostrada.pl>
<zzvoskhboiu9$.dwas1bqu2ol2.dlg@40tude.net>
<6206d9a2$0$470$65785112@news.neostrada.pl>
Reply-To: j...@g...pl
Mime-Version: 1.0
Content-Type: text/plain; charset="utf-8"
Content-Transfer-Encoding: 8bit
Injection-Info: reader02.eternal-september.org;
posting-host="ed8f058c6db0e60a003a1e41af053b3f";
logging-data="20821";
mail-complaints-to="a...@e...org";
posting-account="U2FsdGVkX1/RC1zh1lbu1fpLShAwJW5N"
User-Agent: 40tude_Dialog/2.0.15.1pl
Cancel-Lock: sha1:GErkLhTetAPtUouFhmpx89BvUQY=
X-Face: 4hY-vJY/j3P@Ah)-U9"n^5EAM]~m_]t{I$LOF/]iz~fNN(6D47ug[9>GO}/"c5.)C?Wc[Agpb\}/6
t.<O
Xref: news-archive.icm.edu.pl pl.soc.prawo:821854
[ ukryj nagłówki ]
Dnia Fri, 11 Feb 2022 22:48:17 +0100, Shrek napisał(a):

> Dla przypomnienie - pfizer po dwóch dawkach i 25 tygodniach - 10%. Astra
> zero po 20 tygodniach.
> https://www.gov.uk/government/publications/covid-19-
vaccine-weekly-surveillance-reports
>
> Żródełko wygląda legitnie.

No dobrze, zajrzałem. Tam pisze np. tak:

"Vaccine effectiveness
Several studies of vaccine effectiveness have been conducted in the UK
which indicate that 2
doses of vaccine are between 65 and 95% effective at preventing
symptomatic disease with
COVID-19 with the Delta variant, with higher levels of protection
against severe disease
including hospitalisation and death. There is some evidence of waning of
protection against
infection and symptomatic disease over time, though protection against
severe disease remains
high in most groups at least 5 months after the second dose"

Nijak ma się to do twoich 10%.
--
Jacek
I hate haters.